Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00022035 · ClinicalTrials.gov registry record · NA
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
A NA study of Leukemia and Infection, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 2
- Study locations
NCT00022035: Completed NA study of Leukemia and Infection, sponsored by Roswell Park Cancer Institute.
NCT00022035 is a NA study of Leukemia and Infection that has completed, run by Roswell Park Cancer Institute. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00022035, a NA study of Leukemia and Infection, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2
- Study locations
Study Summary
RATIONALE: Flu vaccine may help the body build an immune response and decrease the occurrence of flu in children who are receiving chemotherapy for acute lymphoblastic leukemia. PURPOSE: Clinical trial to study the effectiveness of vaccine therapy in preventing flu in children who have acute lymphoblastic leukemia.
Interventions
- BIOLOGICAL trivalent influenza vaccine
Study Locations (2)
New Jersey
- Hackensack University Medical Center - Hackensack
New York
- Roswell Park Cancer Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-08 |
| Phase | NA |
What the finished NCT00022035 record still lists
NCT00022035 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 2 conditions, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which trivalent influenza vaccine is the first listed.
NCT00022035 reports a single indexed study location in New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT00022035 about?
NCT00022035 is a clinical study titled "Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia". RATIONALE: Flu vaccine may help the body build an immune response and decrease the occurrence of flu in children who are receiving chemotherapy for acute lymphoblastic leukemia. PURPOSE: Clinical trial to study the effectiveness of vaccine therapy in preventing flu in children who have acute lympho...
What is the current status of trial NCT00022035?
This trial is currently completed. It is a NA study. The study started on 2000-08.
What conditions does trial NCT00022035 study?
This clinical trial studies the following conditions: Leukemia, Infection.
What interventions are being tested in trial NCT00022035?
The interventions under investigation include: trivalent influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00022035?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00022035 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
RECRUITING · NA
-
I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients
RECRUITING · NA
-
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
RECRUITING · NA
-
HEME Home Transfusion Program
RECRUITING · NA
-
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia